•  
  •  
  •  
  •  

2025-10-01 21:53:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  INE298J01013

Research

  • Q4FY22 Result Update - Nippon Life India AMC - ICICI Direct

Stock Report

  • Nippon Life India Asset Management Ltd recommends final dividend of Rs. 10
  • Nippon India Mutual Fund launches Nippon India Nifty 500 Momentum 50 Index Fund
  • Nippon Life India Asset Management Ltd recommends final dividend of Rs. 11
  • Nippon Life India AIF Management Ltd appoints Ashish Chugani as New Head of Alternative Assets business
  • Mr. U.K. Sinha joins NAM India as an Independent Director & Chairman of its Board
  • Nippon Life India Asset Management Ltd recommends final dividend of Rs. 7.50
  • Nippon Life India Asset Management elevates Mr. Sailesh Bhan as its new CIO - Equity
  • Nippon Life India Asset Management Ltd recommends final dividend of Rs. 7.50
  • NAM India gets IFSCA approval to carry out PMS from Gift City, Gandhinagar
  • Nippon Life India Asset Management Limited declares interim dividend of Rs. 3.50

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024